Mad in America
OCTOBER 28, 2023
O n September 9, Mad in America set up a petition on change.org urging the American Journal of Psychiatry to retract its 2006 article that told of a 67% remission rate in the STAR*D trial. At that time, we put up a petition on change.org urging that the Am J of Psychiatry retract the 2006 article. Mad in America, a U.S.
Mad in America
FEBRUARY 8, 2025
One would have thought that suicide is a hard endpoint and that we can believe analyses carried out by drug regulators based on the clinical study reports the manufacturers have submitted to them, but this is not so. FDA 2006; Nov 16. Restoring the two pivotal fluoxetine trials in children and adolescents with depression.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
MARCH 21, 2024
We cited research based on the clinical study reports the manufactures had submitted to drug regulators to get their drugs approved for children and adolescents and other research in our letter. 4,5 I asked Emslie and the manufacturer, Eli Lilly, if they wanted to restore the trials. FDA 2006;Nov 16. The fraud was grave.
Mad in America
AUGUST 3, 2024
A 2006 National Institute of Mental Health (NIMH) study, “ The Naturalistic Course of Major Depression in the Absence of Somatic Therapy ,” examined depressed patients who had recovered from an initial episode of depression, then relapsed but did not take any medication following their relapse.
Mad in America
SEPTEMBER 7, 2024
That rate has been increasing rapidly: “From 2006 to 2014, the number of serious ADEs reported to the FDA increased 2-fold… A previously published study… found that from 1998 to 2005, there was a 2.6-fold This move “transformed pharmaceutical outfits into companies who market drugs rather than companies who manufacture drugs for the market.”
Mad in America
MARCH 15, 2025
Establishment psychiatry has shown this same unscientific thinking in its manufacturing of other biological theories of mental illness. Psychiatry has offered various chemical imbalanceor monoamine imbalance theories for depression. news story , I Lost Everything’: Inside Britain’s ‘Worrying’ Ketamine Problem).
Mad in America
SEPTEMBER 14, 2024
While the ongoing logistics of maintaining such a network have proved challenging, one such successful effort in 2006 was documented in The Wall Street Journal. Somatics LLC marked a watershed moment for advocates who have fought for decades for ECT device manufacturer accountability.
Expert insights. Personalized for you.
145 
Let's personalize your content